TH125503A - The use of Ivaradine as a diagnostic agent in the coronary method Angiography By multislize computer - Google Patents
The use of Ivaradine as a diagnostic agent in the coronary method Angiography By multislize computerInfo
- Publication number
- TH125503A TH125503A TH901004950A TH0901004950A TH125503A TH 125503 A TH125503 A TH 125503A TH 901004950 A TH901004950 A TH 901004950A TH 0901004950 A TH0901004950 A TH 0901004950A TH 125503 A TH125503 A TH 125503A
- Authority
- TH
- Thailand
- Prior art keywords
- methyl
- ivabradine
- dimethoxy
- salts
- angiography
- Prior art date
Links
- 238000002583 angiography Methods 0.000 title claims 2
- 239000000032 diagnostic agent Substances 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 6
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 239000011780 sodium chloride Substances 0.000 claims abstract 6
- ACRHBAYQBXXRTO-OAQYLSRUSA-N Ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 claims abstract 5
- 229960003825 ivabradine Drugs 0.000 claims abstract 5
- 239000002253 acid Substances 0.000 claims abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 238000002586 coronary angiography Methods 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 238000003325 tomography Methods 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
Abstract
DC60 (02/12/54) การใช้ของไอวาบราดีน (ivabradine) , หรือ 3-{3-[{[(7S)-3,4-ไดเมทธอกซี-ไบไซโคล [4.2.0]ออกทา-1,3,5-ไตรเอน-7-อิล]เมทธิล}(เมทธิล)อะมิโน]โพรพิล}-7,8-ไดเมทธอกซี-1,3,4,5- เตตราไฮโด ร-2H-3-เบนซาเซพิน-2-โอน , ของเกลือของการเติมของมันด้วยกรดที่ยอมรับได้ทาง เภสัชกรรม และของไฮเดรทของเกลือของพวกมัน , ในฐานะสารที่เกี่ยวกับการวินิจฉัยโรคในวิธีการ ของโคโรนารี แองจิโอกราฟฟี โดยมัลติสไลซ์ คอมพิวเทด โทโมกราฟฟี การใช้ของไอวาบราดีน, (ivabradine) หรือ 3-{3-[{[(7S)-3,4-ไดเมทธอกซี-ไบไซโคล [4.2.0]ออกทา-1,3,5-ไตรเอน-7-อิล]เมทธิล}(เมทธิล)อะมิโน]โพรพิล}-7,8-ไดเมทธอกซี-1,3,4,5- เตตราไฮโดร-2H-3-เบนซาเซพิน-2-โอน, ของเกลือของการเติมของมันด้วยกรดที่ยอมรับได้ทาง เภสัชกรรม และของไฮเดรทของเกลือของพวกมัน, ในฐานะสารที่เกี่ยวกับการวินิจฉัยโรคในวิธีการ ของโคโรนารี แองจิโอกราฟฟี โดยมัลติสไลซ์ คอมพิวเทด โทโมกราฟฟี สิทธิบัตรยา DC60 (02/12/54) Use of ivabradine (ivabradine), or 3- (3 - ((((7S) -3,4-dimethoxy-bycloid)). [4.2.0] oct-1,3,5-trien-7-il] methyl} (methyl) amino] propyl} -7,8-dimethoxy- 1,3,4,5-tetrahydro-2H-3-benzacepin-2-transfer, of the salts of its addition with a pharmaceutical acceptable acid, and of the hydrate of their salts. It, as a diagnostic substance in the coronary angiography method By multiplying the computable tomography, the use of ivabradine, (ivabradine) or 3- (3 - ((((7S) -3,4-dimethoxy-bi)). Cycloid [4.2.0] oct-1,3,5-trien-7-il] methyl} (methyl) amino] propyl} -7,8-dimethoxy- 1,3,4,5-tetrahydro-2H-3-benzacepin-2-transfer, of salts of their additions with pharmacically acceptable acids and of hydrates of their salts. , As a diagnostic substance in the coronary angiography method By Multi-sliced Computable Tomography, Drug Patent
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH125503B TH125503B (en) | 2013-07-17 |
| TH125503A true TH125503A (en) | 2013-07-17 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2582779T3 (en) | Oral dosage form of acetaminophen / tramadol extended release | |
| BRPI1015338B8 (en) | liquid pharmaceutical formulation, use of a salt, compound and container equipped with a drip aggregate | |
| BRPI1014595A2 (en) | procedure for obtaining new naphthalene derivatives for the in vivo diagnosis of alzheimer's disease | |
| TH125503A (en) | The use of Ivaradine as a diagnostic agent in the coronary method Angiography By multislize computer | |
| TH125503B (en) | The use of Iwabradine as a diagnostic agent in the coronary method Angiography By multislize computerized tomography | |
| ME00953B (en) | Ivabradine and its use in a method of diagnosis using coronary angiography with multi-slice computed tomography | |
| JP2013538819A5 (en) | ||
| CU20090186A7 (en) | IVABRADINA INJECTABLE COMPOSITION | |
| JP2011010618A5 (en) | ||
| Radhakrishnan et al. | 159 Myocardial fibrosis is associated with reduced coronary flow velocity reserve in end-stage renal disease | |
| Handa | Quantitative myocardial FDG uptake by positron emission tomography in rat heart and its application for longitudinal multiple studies in progressive hypertrophy of heart model | |
| CN201701510U (en) | Tablet capsule filled with salbutamol sulfate tablet and ambroxol hydrochloride tablet | |
| TH81375A (en) | New compound | |
| WHITE et al. | A. PEARCE AND S. McCCORKELL 9 Tracheostomy J. VARLEY AND F. FALTER 10 Venous access JE ARROWSMITH | |
| TH112269A (en) | Pharmacy acceptable salt of (3 - ([[3- (6-amino-2-butoxi-8-oxo-7,8-dihydro-9H-purin-9-il) propyl) (3-morpholin-4-ilpropyl) amino) - methyl)-phenyl) acetate And use in the treatment of disease | |
| TH109186A (en) | A new process for the synthesis of Ivaradine and its salts, the addition of it with a pharmaceutical acceptable acid. | |
| TH107683B (en) | A new process for the synthesis of ivabradine and salt. The addition of this substance is ready. With acids acceptable by pharmaceuticals | |
| Chen et al. | Nanoparticle-mediated delivery of angiotensin II receptor antagonist, olmesartan medoxomil into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension in rats | |
| Hashimoto et al. | Serum magnesium, ambulatory blood pressure, and the prevalence of carotid artery alteration: The Ohasama study | |
| TH139453A (en) | Pharmaceutical formulas | |
| TH125475A (en) | Oral care products and methods of use and manufacture of them | |
| UA64595U (en) | method for estimation of efficiency of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type with bisoprolol | |
| TH85272A (en) | The use of acomelatine as a pharmaceutical drug intended for the treatment of bipolar disorder. | |
| TH111681A (en) | Catecholamine derivatives and their products | |
| TH126215A (en) | Improves bone metabolism. |